Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroectodermal Tumors, Primitive × ibrutinib × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 38 Lymphoma, Mantle-Cell 16 Waldenstrom Macroglobulinemia 11 Lymphoma, Follicular 10 Lymphoma, Large B-Cell, Diffuse 8 Lymphoma, B-Cell 8 Lymphoma 8 Lymphoma, Non-Hodgkin 7 Leukemia 7 Recurrence 6 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphoid 4 Leukemia, B-Cell 4 Multiple Myeloma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lung Neoplasms 2 Leukemia, Prolymphocytic 2 Leukemia, Myeloid, Acute 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Chromosome 17 deletion 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Bronchiolitis Obliterans Syndrome 2 Smoldering Multiple Myeloma 1 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Metastatic Pancreatic Adenocarcinoma 1

Interventions

antineoplaston AS 2-1 3 antineoplaston A10 3 dactolisib 2 Temozolomide 2 Irinotecan 2 Everolimus 2 Bevacizumab 2 spartalizumab 1 poly ICLC 1 plerixafor 1 pasireotide 1 fosbretabulin 1 cixutumumab 1 adavosertib 1 Vaccines 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Radiation 1 PM 00104 1 Lapatinib 1 Immunologic Techniques 1 Immunoglobulin G 1 Genistein 1 Fentanyl 1 Donepezil 1 Disulfides 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡